Abbott Patent Application for HIV Spurned

4 Jan 2011

The Economic Times reports on how the Mumbai patent office has rejected drug maker Abbott Laboratories’ patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented.Full story here.

Partner with us now to build
a more just and equitable
medicine system for all.